AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Mainz Biomed N.V. Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI AK-C4F4FC36D2
1.01▼ 0.01 (-0.98%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.02
Day's Range
0.95 – 1.02
52-Week Range
0.30 – 4.93
Volume
479.6K
Avg Volume
439.4K
Share Statistics
Shares Outstanding
Employees
13
Exchange
XNAS
Listed
2021-11-05
Share count as of August 13, 2026

Mainz Biomed N.V. Ordinary Shares (QUCY) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Mainz Biomed N.V. Ordinary Shares (QUCY)
What is Mainz Biomed N.V. Ordinary Shares's Market Cap?
Mainz Biomed N.V. Ordinary Shares's Market Cap is $84.9M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Enterprise Value?
Mainz Biomed N.V. Ordinary Shares's Enterprise Value is $80.2M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Price / Sales?
Mainz Biomed N.V. Ordinary Shares's Price / Sales is 158.1×, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EV / Revenue?
Mainz Biomed N.V. Ordinary Shares's EV / Revenue is 149.3×, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EV / EBITDA?
Mainz Biomed N.V. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Revenue (TTM)?
Mainz Biomed N.V. Ordinary Shares's Revenue (TTM) is $537.1K, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Net Income (TTM)?
Mainz Biomed N.V. Ordinary Shares's Net Income (TTM) is -$16.3M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EBITDA?
Mainz Biomed N.V. Ordinary Shares's EBITDA is -$15.3M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM)?
Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM) is -0.19, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EBITDA Margin?
Mainz Biomed N.V. Ordinary Shares's EBITDA Margin is -2856.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · QUCYAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses:
Sales and marketing
Research and development
In-process research and development—
General and administrative
Total operating expenses
Loss from operations
Other income (expense)
Other income
Change in fair value of convertible debt——
Interest expense
Other expense
Total other expense
Loss before income tax
Loss from continuing operations
Loss from discontinued operations
Net loss
Net loss
Net loss, basic (in Dollars per share)
Net loss, diluted (in Dollars per share)